Security key
04280A100
ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)
CUSIP: 04280A100
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 66,549,683
- Total 13F value
- $4,154,048,742
- Share change
- -523,769
- Put/Call ratio
- 67%
- SEC-reported price per share
- $62.43
- Number of holders
- 282
- Value change
- -$66,618,101
- Number of buys
- 133
- Number of sells
- 148
- Shares outstanding
- 141,328,976
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
282
Top holders
10
ARWR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
ARROWHEAD PHARMACEUTICALS, INC. SEC filings
ARROWHEAD PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04280A100
Recent filing periods:
Ownership snapshot
Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 8.6%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 8.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
8.6%
VANGUARD GROUP INC
6.8%
STATE STREET CORP
2.5%
Johnson & Johnson Innovation - JJ...
2.3%
JPMORGAN CHASE & CO
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
8.6%
|
$1,006,221,000
12,149,503 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
6.8%
|
$798,307,000
9,639,064 shares
|
— | 30 Jun 2021 |
| STATE STREET CORP |
13F
Company
|
2.5%
|
$297,020,000
3,586,331 shares
|
— | 30 Jun 2021 |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
Company
|
2.3%
|
$270,065,000
3,260,869 shares
|
— | 30 Jun 2021 |
| JPMORGAN CHASE & CO |
13F
Company
|
1.9%
|
$219,145,000
2,646,045 shares
|
— | 30 Jun 2021 |
| Invesco Ltd. |
13F
Company
|
1.8%
|
$207,590,000
2,506,516 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
282
Shares
66,549,683
Rows available
282
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
304
Q3 2021 holders
282
Holder diff
-22
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend